Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc.

DLTNF
Delta 9 Cannabis Inc.US flagOther OTC
0.01
USD
+0.00
- -
3.04MMarket Cap
Delta 9 Cannabis Inc.
DLTNF
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
1.21
0.47
0.48
5.61
- -
- -
- -
- -
- -
0.02
0.09
0.36
0.58
0.6
0.5
- -
0.38
Revenue per Share
-3.13
0.34
-1.12
-3.49
-0.18
0.59
-0.14
0.15
-0.07
-0.16
-0.1
0.12
-0.07
-0.11
-0.22
- -
-0.11
Basic EPS, GAAP
-0.4
0.05
-0.39
-0.88
-0.06
-0.05
-0.07
-0.01
-0.19
-0.1
-0.32
-0.3
-0.05
-0.03
-0.05
- -
0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-11.73
-11.38
-12.5
-32.8
-3.16
-2.57
-2.71
-2.56
-0.95
0.48
0.39
0.51
0.51
0.36
0.14
- -
0.01
Book Value per Share
0.25
0.59
-0.03
-6.08
-1.02
-0.43
-0.57
-0.42
-0.05
0.5
0.43
0.36
0.36
0.21
-0.06
- -
-0.13
Tangible Book Value per Share
1
1
1
- -
1
1
1
1
3
49
81
87
89
103
126
- -
184
Basic Weighted Avg Shares
1
1
1
1
- -
- -
- -
- -
- -
1
8
32
52
62
63
71
71
Sales/Revenue/Turnover
-225.59
-233.43
-182.72
-70.09
- -
- -
- -
- -
- -
-818.9
-112.31
-15.88
-5.32
-12.26
-32.04
-18.99
-21.54
Operating Margin (%)
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
4
5
6
8
9
9
Depreciation Expense
-3
- -
-1
- -
- -
1
- -
- -
- -
-8
-8
11
-6
-11
-27
-18
-20
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-257.98
72.73
-232.19
-62.23
- -
- -
- -
- -
- -
-833.65
-112.11
34.32
-12.33
-17.94
-43.02
-24.65
-27.74
Profit Margin (%)
- -
- -
- -
-1
-1
- -
-1
- -
- -
24
20
13
17
-10
-26
-28
-39
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5
20
27
8
29
33
25
LT Debt
- -
1
- -
-1
-1
- -
-1
- -
- -
25
35
31
33
25
7
-6
-10
Total Equity
- -
-263.9
- -
- -
- -
- -
- -
- -
- -
- -
- -
-10.04
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
-2.98
- -
- -
- -
-23.07
- -
-5.99
- -
- -
- -
23.45
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-30.78
28.59
-14.29
-27.3
-99.41
-156.9
-231.74
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
31
31
40
LT Borrowings
16
15
6
LT Finance Leases
19
18
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
175
213
257
Market Capitalization
8
4
9

Working Capital

FRC

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
22
18
16
Cash, Cash Equivalents & STI
2
2
1
Accounts Receivable, Net
2
2
2
Inventories
16
12
11
Total Current Liabilities
45
46
55
Payables & Accruals
14
14
14
ST Debt
31
31
40
Deferred Revenue
1
1
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,658.61%
-60.11%
-198.29%
Free Cash Flow
558.31%
-37.3%
-159.29%
Net Income, GAAP
297.6%
-41.08%
-35.61%
Sales/Revenue/Turnover
- -
83.42%
12.39%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
12
17
16
18
63
2023
17
18
18
17
71
2024
16
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.04
-0.04
-0.06
- -
-0.22
2023
-0.02
-0.02
-0.03
- -
- -
2024
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
Delta 9 Cannabis Inc. Delta 9 Cannabis Inc. operates as a vertically integrated cannabis company in Canada, focusing on the cultivation, processing, extraction, wholesale distribution, retail sale, and medical consultation services for medical and recreational cannabis products. The company produces and sells dried cannabis flowers, pre-rolls, dried sift cannabis, oils, extracted and derivative products including high-terpene milled flower and vape cartridges under brands such as Delta 9 Cannabis, Busted Nugs, RAZL, and 770 Cannabis; it also offers proprietary cannabis grow pods and live plants to other licensed producers, operates retail stores under the Delta 9 Cannabis Store brand across Canadian provinces including Manitoba, Alberta, British Columbia, Ontario, Newfoundland, and Yukon, and exports products to Australia while providing physician consultations through Delta 9 Lifestyle Cannabis Clinic Inc. Wholly-owned subsidiary Delta 9 Bio-Tech Inc. manages production at a 95,000 square foot facility in Winnipeg, Manitoba, with supply agreements in multiple provinces and capabilities for automated bottling and rolling. Founded in 2001 and headquartered in Winnipeg, Manitoba, the company entered creditor protection under the Companies’ Creditors Arrangement Act in July 2024, facilitating a transaction where The FIKA Company acquired its cannabis retail store and logistics businesses, while Simply Solventless Concentrates Ltd. completed the acquisition of Delta 9 Bio-Tech Inc. in February 2025 through a court-approved reverse vesting order.

Company News

APIChat